Cell adhesion molecules (CAMs) are found on the surfaces of all cells, where they bind to extracellular matrix molecules or to receptors on other cells. As well as having a structural role, CAMs function as signaling receptors, transducing signals initiated by cellular interactions which regulate many diverse processes, including cell division, migration, and differentiation. Cell adhesion molecules are essential for maintaining stable tissue structure. However, cell adhesion must be dynamic to facilitate the mobility and turnover of cells. In dynamic situations, cells alter their cell-cell and cell-matrix interactions by virtue of altered expression and function of CAMs. The expression of CAMs is normally tightly regulated, thereby controlling cell proliferation, mobility, differentiation, and survival. Many of these processes are misregulated in malignant tumors, and it has been shown that many of the characteristics of tumor cells are attributable to the aberrant expression or function of CAMs. Integrins and E-cadherin are the most important CAMs expressed by stratified squamous epithelium. Altered expression of these molecules has been found in oral carcinoma, where loss of CAM expression is often seen in poorly differentiated lesions. However, up-regulation of certain integrins, such as av(36, has consistently been found in oral cancer, suggesting that it may play an active role in disease progression.
References
1.
Adams JC, Watt FM ( 1991). Expression of β1, β3, β4 and β5 integrins by human epidermal keratinocytes and non-differentiating keratinocytes. J Cell Biol115:829-841.
2.
Agrez M., Chen A., Cone RI, Pytela R., Sheppard D. (1994). The αvβ6 integrin promotes proliferation of colon carcinoma cells through a unique region of the β6 cytoplasmic domain. J Cell Biol127:547-556.
3.
Agrez M., Bates RC, Mitchell D., Wilson N., Ferguson N., Anseline P., et al. (1996). Multiplicity of fibronectin-binding alpha v integrin receptors in colorectal cancer. Br J Cancer73:887-892.
4.
Albelda SM, Buck CA ( 1991). Molecular and cellular properties of PECAM-1 (ENDOcam/cd31): a novel vascular cell adhesion molecule. J Cell Biol114:1059-1068.
5.
Albeda SM, Mette SH, Elder DE, Stewart R., Damjanovich L., Herlyn M., et al. (1990). Integrin distribution in malignant melanoma: association of the β3 subunit with tumour progression. Cancer Res50:6757-6764.
6.
Amagai M., Kalus-Kovtun V., Stanley JR (1991). Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell67: 869-877.
7.
Andre F., Rigot V., Thimonier J., Montixi C., Parat F., Pommier G., et al. (1999). Integrins and E-cadherin cooperate with IGF-1 to induce migration of epithelial colonic cells. Int J Cancer83:497-505.
8.
Arap W., Pasqualini R., Ruoslahti E. (1998). Cancer treatment by targetted drug delivery to tumour vasculature in a mouse model. Science279:377-380.
9.
Arch R., Worth K., Hofman M., Ponta H., Matzku S., Herrlich P., et al. (1992). Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science257:682-685.
10.
Bachelder RE, Marchetti A., Falcioni R., Soddu S., Mercurio AM (1999). Activation of p53 function in carcinoma cells by the alpha 6 beta 4 integrin. J Biol Chem274:20733-20737.
11.
Bagutti C., Speight PM, Watt FM ( 1998). Comparison of integrin, cadherin and catenin expression in squamous cell carcinoma of the oral cavity. J Pathol186:8-16.
12.
Behrens J. (1999). Cadherins and catenins: role in signal transduction and tumour progression. Cancer Met Rev18:15-30.
13.
Behrens J., Mareel MM, Van Roy F., Birchmeier W. (1989). Dissecting tumor cell invasion: epithelial cells aquire invasive properties after the loss of uvomorulin-mediated cell adhesion. J Cell Biol109:2435-2447.
14.
Behrens J., Vakaet L., Friis R., Winterhager E., Van Roy F., Mareel MM, et al. (1993). Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/β catenin complex in cells transformed with a temperature sensitive v-src gene. J Cell Biol120:757-766.
15.
Benchimol S., Fuks A., Jothy S., Beauchemin N., Shirota K., Stanners C. (1989). Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell57:327-334.
16.
Bevilacqua MP, Nelson RM (1993). Selectins. J Clin Invest91:379-387.
17.
Bevilacqua MP, Stengelin S., Gimbrone MA, Seed B. ( 1989). Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science243:1160-1165.
18.
Birch M., Mitchell S., Hart IR ( 1991). Isolation and characterisation of human melanoma cell variants expressing high and low levels of CD44. Cancer Res51:6660-6667.
19.
Borchers AH, Sanders LA, Bowden GT (1997). Regulation of matrilysin expression in cells of squamous cell carcinoma by E-cadherin mediated cell-cell contact. J Cancer Res Clin Oncol123:13-20.
20.
Bourguignon LY, Gunja-Smith Z., Iida N., Zhu HB, Yiung LJ, Muller WJ, et al. (1998). CD44v3,8-10 is involved in cytoskeletal-mediated tumour cell migration and matrix metalloproteinase (MMP-9) association in breast cancer cells. J Cell Physiol176:206-215.
21.
Bowie GL, Caslin AW, Roland NJ, Field JK, Jones AS, Kinsella AR (1993). Expression of the cell-cell adhesion molecule E-cadherin in squamous cell carcinoma of the head and neck. Clin Otolaryngol18:196-201.
22.
Breuss JM, Gallo J., DeLisser HM, Klimanskaya IV, Folkesson HG, Pittet JF, et al. (1995). Expression of the (36 subunit in development, neoplasia and tissue repair suggests a role in epithelial remodelling. J Cell Sci108:2241-2251.
23.
Brooks PC, Montgomery AMP, Rosenfeld M., Reisfeld RA, Hu T., Klier G., et al. (1994). Integrin αvβ3 antagonists promote tumour regression by inducing apoptosis of angiogeneic blood vessels. Cell79:1157-1164.
24.
Brooks PC, Stromblad S., Sanders LC, Von Schalscha TL, Aimes RT, Stetler-Stevenson WG, et al. (1996). Localisation of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell85:683-693.
25.
Brown DW, Furness J., Speight PM, Thomas GJ, Li J., Thornhill MH, et al. (1999). Mechanisms of binding of cutaneous lymphocyte-associated antigen-positive and αeβ7-positive lymphocytes to oral and skin keratinocytes. Immunology98:9-15.
26.
Buck CA ( 1992). Immunoglobulin superfamily: structure, function and relationship to other receptor molecules. Semin Cell Biol3:179-188.
27.
Bukholm IK, Nesland JM, Karesen R., Jacobsen U., Borreson-Dale AL (1998). E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma. J Pathol185:262-266.
28.
Bukholm IK, Nesland JM, Borreson-Dale AL (2000). Re-expression of E-cadherin, a-catenin and β-catenin but not of γ-catenin in metastatic tissue from breast cancer patients. J Pathol190:15-19.
29.
Buckley CD, Doyonnas R., Newton JP, Blystone SD, Brown EJ, Watt FM, et al. (1996). Identification of αvβ3 as a heterotypic ligand for CD31/PECAM-1. J Cell Sci109:437-445.
30.
Butcher EC (1990). Cellular and molecular mechanisms that direct leukocyte traffic. Am J Pathol136:3-11.
31.
Butcher EC (1991). Leukocyte-endothelial recognition: three (or more) steps to specificity and diversity. Cell67:1033-1037.
32.
Carter WG, Wayner EA, Bouchard TS, Kaur P. ( 1990). The role of integrins α2β1 and α3β1 in cell-cell and cell-substrate adhesion of human epidermal cells. J Cell Biol110:1378-1404.
33.
Collins JE, Legan PK, Kenny TP, Macgarvie J., Holton JL, Garrod DR (1991). Cloning and sequence analysis of desmosomal glycoprotein 2 and 3 (desmocollins): cadherin-like desmosomal adhesion molecules with heterogenous cytoplasmic domains. J Cell Biol113:381-391.
34.
Combaret V., Lasset C., Frappaz D., Bouvier R., Thiesse P., Rebillard AC, et al. (1995). Evaluation of CD44 prognostic value in neuroblastoma: comparison with the other prognostic factors. Eur J Cancer31:545-549.
35.
Cortesina G., Sacchi M., Bussi M., Panizzut B., Ferro S., Carlevato MT, et al. (1990). Integrin expression in head and neck cancers. Acta Otolaryngol115:328-330.
36.
Crawford JM, Hopp B. ( 1990). Junctional epithelium expresses the intercellular adhesion molecule ICAM-1. J Periodontal Res25:254-256.
37.
Damsky CH, Richa J., Solter D., Knudsen K., Buck CA ( 1983). Identification and purification of a cell surface glycoprotein mediating intercellular adhesion in embryonic and adult tissue. Cell34:455-466.
38.
De Bruin A., Muller E., Wurm S., Caldelari R., Wyder M., Wheelock MJ, et al. (1999). Loss of invasiveness in squamous cell carcinoma cells overexpressing desmosomal cadherins. Cell Ad Comm7:13-28.
39.
DiPersio CM, Hodivala-Dilke KM, Jaenisch R., Kreidberg JA, Hynes RO (1997). Alpha 3 beta 1 integrin is required for normal development of the epidermal basement membrane. J Cell Biol137:729-742.
40.
Dogan A., Wang ZD, Spencer J. (1995). E-cadherin expression in intestinal epithelium. J Clin Pathol48:143-146.
41.
Dorudi S., Sheffield JP, Poulsom R., Northover JMA, Hart IR ( 1993). E-cadherin expression in colorectal cancer. J Pathol142:981-986.
42.
Downer CS, Speight PM (1993). E-cadherin expression in normal, hyperplastic and malignant oral epithelium. Oral Oncol4:303-305.
43.
Downer C., Watt FM, Speight PM (1993). Loss of a6 and β4 integrin subunits coincides with loss of basement membrane components in oral squamous cell carcinoma. J Pathol171:183-190.
44.
Dustin ML, Rothlein R., Bhan AK, Dinarello CA, Springer TA (1986). Induction by IL-1 and interferon γ: tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). J Immunol137:245-254.
45.
Dustin ML, Singer KH, Tuck DT, Springer TA (1988). Adhesion of T lymphocytes to epidermal keratinocytes is regulated by interferon-μ, and is mediated by intercellular adhesion molecule 1 (ICAM-1). J Exp Med167:1323-1340.
46.
Edelman GM, Crossin KL (1991). Cell adhesion molecules: implications for a molecular histology. Annu Rev Biochem60:155-190.
47.
Edwards GM, Streuli CH (1999). Activation of integrin signaling pathways by cell interactions with extracellular matrix. In: Advances in molecular and cell biology. Garrod D, North A, Chidgey M, editors. JAI Press Inc., pp. 237-268.
48.
Elices MJ, Osborn L., Takada Y., Crouse C., Lubkowskyi S., Hemler ME, et al. (1990). VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4 / fibronectin binding site. Cell60:577-584.
49.
Fawcett J., Buckley C., Holness CL, Bird IN, Spragg JH, Saunders J., et al. (1995). Mapping the homotypic binding sites in CD31 and the role of CD31 adhesion in the formation of inter-endothelial cell contacts. J Cell Biol128:1229-1241.
50.
Felding-Habermann B., Mueller BM, Romerdahl CA, Cheresh DA (1992). Involvement of integrin av gene expression in human melanoma tumorigenicity. J Clin Invest89:2018-2022.
51.
Fina L., Molgaard HV, Robertson D., Bradley NJ, Monaghan P., Delia D., et al. (1990). Expression of the CD34 gene in vascular endothelial cells. Blood75:2417-2426.
52.
Fox SB, Turner GD, Leek RD, Whitehouse RM, Gatter KC, Harris AL (1995). The prognostic value of quantitative angiogenesis in breast cancer and role of adhesion molecule expression in tumour endothelium. Breast Cancer Res Treat36:219-226.
53.
Frixen UH, Nagamine Y. (1993). Stimulation of urokinase-type plasminogen activator expression by blockage of E-cadherin-dependent cell-cell adhesion. Cancer Res53:3618-3623.
54.
Fujisaki T., Tanaka Y., Fujii K., Mine S., Saito K., Yamada S., et al. (1999). CD44 stimulation induces integrin-mediated adhesion of colon carcinoma cell lines to endothelial cells by upregulation of integrins and c-Met and activation of integrins. Cancer Res59:4427-4434.
55.
Furukawa F., Takigawa M., Matsuyoshi N., Shirahama S., Wakita H., Fujita M., et al. (1994). Cadherins in cutaneous biology. J Dermatol21:802-813.
56.
Garrod D., Chidgey M., North A. (1996). Desmosomes-differentiation, development, dynamics and disease. Curr Opin Cell Biol8:670-678.
57.
Garzino-Demo P., Carrozzo M., Trusolino L., Savoia P., Gandolfo S., Marchisio PC (1998). Altered expression of alpha 6 integrin subunit in oral squamous cell carcinoma and oral potentially malignant lesions. Oral Oncol34:204-210.
58.
Gehlsen KR, Argraves WS, Pieschbacher MD, Ruoslahti E. (1988). Inhibition of tumor cell migration by Arg-Gly-Asp containing synthetic peptides. J Cell Biol106:925-930.
59.
Giancotti FG, Ruoslahti E. (1990). Elevated levels of the α5β1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell60:849-859.
60.
Groves RW, Allen MH, Ross EL, Ahsan G., Barker Jnwn, MacDonald DM (1993). Expression of selectin ligands by cutaneous squamous cell carcinoma. Am J Pathol143:1220-1225.
61.
Gunthert U. (1993). CD44: a multitude of isoforms with diverse functions. Curr Top Microbiol Immunol184:47-63.
62.
Gunthert U., Hofmann M., Rudy W., Reber S., Zoller M., Haussmann I., et al. (1991). A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell65:13-24.
63.
Hakkinen L., Kainulainen T., Salo T., Grenman R., Larjava H. (1999). Expression of integrin a9 subunit and tenascin in oral leukoplakia, lichen planus and squamous cell carcinoma. Oral Dis5:210-217.
64.
Hamidi S., Salo T., Kainulainen, Lerner K, Larjava H. (2000). Expression of av(36 integrin in oral leukoplakia. Br J Cancer82:1433-1440.
65.
Harada T., Shinohara M., Nakamura S., Shimada M., Oka M. (1992). Immunohistochemical detection of desmosomes in oral squamous cell carcinomas: correlation with differentiation, mode of invasion and metastatic potential. Int J Oral Maxillofac Surg21:346-349.
66.
Hashimoto M., Niwa O., Nitta Y., Takeichi M., Yokoro K. (1989). Unstable expression of E-cadherin adhesion molecules in metastatic ovarian tumor cells. Jpn J Cancer Res80:459-463.
67.
Haubner R., Wester HJ, Reuning U., Senekowitsch-Schmidtke R., Diefenbach B., Kessler H., et al. (1999). Radiolabelled alpha v beta 3 integrin antagonists: a new class of tracers for tumour targetting. J Nuclear Med40:1061-1071.
68.
Haynes BF, Liao HX, Patton KL (1991). The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells3:347-350.
69.
Healy CM, Thornhill MH (1999). Induction of adhesion molecule expression on blood vessels and keratinocytes in recurrent oral ulceration. J Oral Pathol Med28:5-11.
70.
Heider KH, Sproll M., Susani S., Patzelt E., Beaumier P., Ostermann E., et al. (1996). Characterisation of a high affinity monoclonal antibody specific for CD44v6 as a candidate for immunotherapy for squamous cell carcinomas. Cancer Immunol Immunother43:245-253.
71.
Herold-Mende C., Seiter S., Born AI, Patzelt E., Schupp M., Zoller J., et al. (1996). Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. J Pathol179:66-73.
72.
Herrlich P., Zoller M., Pals ST, Ponta H. (1993). CD44 splice variants: metastases meets lymphocytes. Immunol Today14:395-399.
73.
Hodivala KJ, Watt FM ( 1994). Evidence that cadherins play a role in the downregulation of integrin expression that occurs during keratinocyte terminal differentiation. J Cell Biol124:589-600.
74.
Horiguchi Y., Furukawa F., Fujita M., Imamura S. (1994). Ultrastructural localisation of E-cadherin cell adhesion molecule on the cytoplasmic membrane of keratinocytes in vivo and in vitro. J Histochem Cytochem42:1333-1340.
75.
Hormia M., Ylanne J., Virtanen I. (1990). Expression of integrins in human gingiva. J Dent Res69:1817-1823.
76.
Hoteiya T., Hayashi E., Satomura K., Kamata N., Nagayama M. (1999). Expression of E-cadherin in oral cancer cell lines and its relationship to invasiveness in SCID mice in vivo. J Oral Pathol Med28:107-111.
77.
Hsu-Lin S-C., Berman C., Furie B., August D., Furie B. (1984). A platelet membrane protein expressed during platelet activation and secretion. J Biol Chem259:9121-9126.
78.
Huang X., Wu J., Spong S., Sheppard D. (1998). The integrin alpha v beta 6 is critical for keratinocyte migration on both its known ligand, fibronectin and on vitronectin. J Cell Sci111:2189-2195.
79.
Hudson DL, Sleeman J., Watt FM ( 1995). CD44 is the major peanut lectin-binding glycoprotein of human epidermal keratinocytes and plays a role in intercellular adhesion. J Cell Sci108:1959-1970.
80.
Hudson DL, Speight PM, Watt FM ( 1996). Altered expression of CD44 isoforms in squamous cell carcinomas and cell lines derived from them. Int J Cancer66:457-463.
81.
Huhtala P., Tuuttila A., Chow LT, Lohi J., Keski-Oja J., Tryggvason K. (1991). Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92-and 72-kilodalton enzyme genes in HT-1080 cells. J Biol Chem266:16485-16490.
82.
Huhtala P., Humphries MJ, McCarthy JB, Tremble PM, Werb Z., Damsky CH (1995). Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol129: 867-879.
83.
Humphries MJ (1990). The molecular basis and specificity of integrin-ligand interactions. J Cell Sci97:585-592.
84.
Humphries MJ, Olden K., Yamada K. (1986). A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science233:467-470.
85.
Hynes RO (1992). Integrins: versatility, modulation and signaling in cell adhesion. Cell69:11-25.
86.
Iida N., Bourguignon LY (1997). Co-expression of cCD44 variant (v10 / ex14) and CD44S in human mammary epithelial cells promotes tumorigenesis. J Cell Physiol171:152-160.
87.
Ilyas M. (2000). Adhesion molecules in breast cancer: the phoenix in tumour metastasis? J Pathol190:3-5.
88.
Islam S., Carey TE, Wolf GT, Wheelock MJ, Johnsos KR (1996). Expression of N-cadherin by human squamous cell carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J Cell Biol135:1643-1654.
89.
Jalkanen S., Bargatze RF, de-los-Toyos J., Butcher EC (1987). Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95 kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal or synovial endothelial cells. J Cell Biol105:983-990.
90.
Johnson JP, Stade BG, Holzmann B., Schwable W., Reithmuller G. (1989). De novo expression of intercellular adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci USA641:644-650.
91.
Jones J., Sugiyama M., Watt FM, Speight PM (1993). Integrin expression in normal, hyperplastic, dysplastic and malignant oral epithelium. J Pathol169:235-243.
92.
Jones J., Sugiyama M., Speight PM, Watt FM ( 1996). Restoration of αvβ5 integrin in neoplastic keratinocytes results in increased capacity for terminal differentiation and suppression of anchorage independent growth. Oncogene12:119-126.
93.
Jones J., Watt FM, Speight PM (1997). Changes in the expression of av(36 integrins in oral squamous cell carcinoma. J Oral Pathol Med26:63-68.
94.
Jones PH, Watt FM ( 1993). Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell73:713-724.
95.
Kandikonda S., Oda D., Niederman R., Sorkin BC (1996). Cadherin-mediated adhesion is required for normal growth regulation of human gingival epithelial cells. Cell Adhes Commun4:13-24.
96.
Kansas GS (1996). Selectins and their ligands: current concepts and controversies. Blood88:3259-3287.
97.
Kasono K., Blackwell JL, Douglas JT, Dmitriev I., Strong TV, Reynolds P., et al. (1999). Selective gene delivery to head and neck cancer cells via an integrin targetted adenoviral vector. Clin Cancer Res5:2571-2579.
98.
Katayama M., Hirai S., Kamihagi K., Yasumoto M., Kato I. ( 1994). Soluble E-cadherin fragments increased in circulation of cancer patients. Br J Cancer69:580-585.
99.
Keely P., Parise L., Juliano R. (1998). Integrins and GTPases in tumor cell growth, motility and invasion. Trends Cell Biol8:101-106.
100.
Kerr JS, Wexler RS, Mousa SA, Robinson CS, Wexler EJ, Mohamed S., et al. (1999). Novel small molecule alpha v integrin antagonists: comparative anti-cancer efficacy with known angiogenesis inhibitors. Anticancer Res19:959-968.
101.
Kibbelaar RE, Moolenaar KEC, Michalides Rjam, Van Bodegom PC, Vanderschueren RG, Wagenaar SS, et al. (1991). Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma. Eur J Cancer27:431-435.
102.
Kincade PW (1993). Cell adhesion mechanisms utilised for lymphohaemopoiesis. In: Lymphocyte adhesion molecules. Shimizu Y, editor. Austin, TX: RG Landes, pp. 249-279.
103.
Kinsella AR, Bowie GL, Field JK, Jones AS (1994). Expression of the cell-cell adhesion molecule E-cadherin in tongue carcinoma cell lines. J Laryngol Otol108:957-961.
104.
Koch PJ, Walsh MJ, Schmelz M., Goldschmidt MD, Zimbdmann R., Franke WW (1990). Identification of desmoglein, a constitutive desmosomal glycoprotein, as a member of the cadherin family of cell adhesion molecules. Eur J Cell Biol53:1-12.
105.
Koretz K., Schlag P., Boumsell L., Moller P. (1991). Expression of a2, a6 and β1 chains in normal mucosa and in adenomas of the colon, colon carcinomas and their liver metastases. Am J Pathol139:741-750.
106.
Koretz K., Moller P., Lehnert T., Hinz U., Otto HF, Herfarth C. (1995). Effect of CD44v6 on survival in colorectal carcinoma. Lancet345:327-328.
107.
Korhonen M., Laitinen L., Ylanne J., Koukoulis GK, Quaranta V., Juusela H., et al. (1992). Integrin distribution in renal cell carcinomas of various grades of malignancy. Am J Pathol141:1161-1171.
108.
Kosmehl H., Berndt A., Katenkamp D., Hyckel P., Stiller KJ, Gabler U., et al. (1995). Integrin receptors and their relationship to cellular proliferation and differentiation of oral squamous cell carcinoma. J Oral Pathol Med24:343-348.
109.
Krause T., Turner GA (1999). Are selectins involved in metastasis? Clin Exp Metastasis17:183-192.
110.
Kugelman LC, Ganguly S., Haggerty JG, Weissman SM, Milstone LM (1992). The core protein of epican, a heparan sulphate proteoglycan on keratinocytes is an alternative form of CD44. J Invest Dermatol99:381-385.
111.
Kunishi M., Kayada Y., Tsumura M., Yoshiga K., Takada K. (1996). Expression of CD44 variant 6 and its metastatic potential in squamous cell carcinoma of the oral cavity. Jpn J Cancer Chemo23:1045-1048.
112.
Kuryu M., Ozaki T., Nashida K., Shibahara M., Kawai A., Inoue H. (1999). Expression of CD44 avriants in osteosarcoma. J Cancer Res Clin Oncol125:646-652.
113.
Larjava H., Lyons JG, Salo T., Makela M., Koivisto L., Birkedal Hansen H., et al. (1993a). Anti integrin antibodies induce type IV collagenase expression in keratinocytes. J Cell Physiol157:190-200.
114.
Larjava H., Salo T., Haapasalmi K., Kramer RH, Heino J. (1993b). Expression of integrins and basement membrane components by wound keratinoyctes. J Clin Invest92:1425-1435.
115.
Larjava H., Haapasalmi K., Salo T., Wiebe C., Uitto VJ (1996). Keratinocyte integrins in wound healing and chronic inflammation of the human periodontium. Oral Dis2:77-86.
116.
Lauri D., Needham L., Martin-Padura I., Dejana E. (1991). Tumour cell adhesion to endothelial cells: endothelial leukocyte adhesion molecule-1 as an inducible receptor for colon carcinoma cells. J Natl Cancer Inst83:1321-1324.
117.
Lesley J., Howes N., Perschl A., Hyman R. (1994). Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J Exp Med108:383-387.
118.
Lewinsohn DM, Bargatze RF, Butcher EC (1987). Leukocyte-endothelial recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes and other leukocytes. J Immunol138:4313-4
119.
Lewis JE, Jensen PJ, Wheelock MJ (1994). Cadherin function is required to assemble desmosomes and stratify in response to calcium. J Invest Dermatol102:870-877.
120.
Li J., Mahiouz DL, Farthing PM, Haskard DO, Thornhill MH (1996). Heterogenicity of ICAM-1 expression, and cytokine regulation of ICAM-1 expression in skin and oral keratinocytes. J Oral Pathol Med25:112-118.
121.
Liu CM, Sheen TS, Shun CT ( 1999). Circulating intercellular adhesion molecule 1 (ICAM-1), E-selectin and vascular cell adhesion molecule 1 (VCAM-1) in head and neck cancer. Br J Cancer79:360-362.
122.
Llorens A., Rodrigo I., Lopez-Barcons L., Gonzalez-Garrigues M., Lozano E., Vinyals A., et al. (1998). Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression. Lab Invest78:1131-1142.
123.
Luo J., Lubaroff DM, Hendrix MJ (1999). Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection. Cancer Res59:3552-3556.
124.
Mackay CR, Terpe H.-J, Stauder R., Marston WL, Stark H., Gunthert U. (1994). Expression and modulation of CD44 isoforms in humans. J Cell Biol124:71-82.
125.
Mackenzie I., Dabelsteen E., Mandel U. (1989). Expression of blood group antigen-related carbohydrates by human gingival epithelia. J Periodontal Res24:289-297.
126.
Maio M., Gulwani B., Langer JA, Kerbel RS, Duigou GJ, Fisher PB, et al. (1989). Modulation by interferons of HLA antigen, high molecular weight melanoma-associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential. Cancer Res49:2980-2987.
127.
Majuri M., Mattila LP, Renkonen R. (1992). Recombinant E-selectin protein mediates tumour cell adhesion via sialyl-Lea and sialyl-Lex. Biochem Biophys Res Commun182:1376-1382.
128.
Marchisio PC, Bondanza S., Cremona O., Concedda R., De Luca M. (1991). Polarised expression of integrin receptors (α6β4, α2β1, a3(31 and av(35) and their relationship with the cytoskeleton and basement membrane matrix in cultured human keratinocytes. J Cell Biol112:761-773.
129.
Marshall JF, Davies D. (1999). The role of integrin-mediated processes in the biology of metastasis. In: Cancer metastasis, molecular and cellular biology and clinical aspects. Jiang WG, Mansel RE, editors (in press).
130.
Marshall JF, Davies D. (2000). The role of integrin-mediated processes in the biology of metastasis. In: Cancer metastasis, molecular and cellular biology mechanisms and clinical intervention. Jiang WG, Mansel RE, editors. London, UK: Kluwer Academic Publishers.
131.
Matsumura Y., Tarin D. (1993). Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet340:1053-1058.
132.
Matsuura K., Kawanishi J., Fujii S., Imamura M., Hirano S., Takeichi M., et al. (1992). Altered expression of E-cadherin in gastric cancer tissues and carcinomatous fluid. Br J Cancer66:1122-1130.
133.
Matsuyoshi N., Tanaka T., Toda K.-I, Okamoto H., Furukawa F., Imamura S. (1995). Soluble E-cadherin: a novel cutaneous disease marker. Br J Dermatol132:745-749.
134.
Mattijssen V., Peters HM, Schalkwijk L., Manni JJ, Van't Hof-Grootenboer B., de Mulder PM, et al, (1993). E-cadherin expression in head and neck squamous cell carcinoma is associated with clinical outcome. Int J Cancer55:580-585.
135.
Mayer B., Johnson JP, Leitl F., Jauch KW, Heiss MM, Schildberg FW, et al. (1993). E-cadherin expression in primary and metastatic gastric cancer: downregulation correlates with cellular differentiation and glandular disintegration. Cancer Res53:1690-1695.
136.
McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L., Bainton DF (1989). GMP-140, a platelet alpha granule membrane protein, is also synthesised by vascular endothelial cells and is localised in Weibel-Palade bodies. J Clin Invest84:92-99.
137.
Miyaki M. (1995). Increased cell adhesiveness and decreased tumorigenicity induced in human colon carcinoma cells by transfection with E-cadherin cDNA. J Clin Med53:1585-1589.
138.
Miyata M., Shiozaki H., Iihara K., Shimaya K., Oka H., Kadowaki T. (1994). Relationship between E-cadherin expression and lymph node metastasis in human oesophageal cancer. Int J Oncol4:61-65.
139.
Morin PJ, Sparks AB, Korinek V., Barker N., Clevers H., Vogelstein B., et al. (1997). Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science275:1787-1789.
140.
Muller WA, Weigl SA, Deng X., Phillips DM (1993). PECAM -1 is required for transendothelial migration of leukocytes. J Exp Med178:449-460.
141.
Muta H., Noguchi M., Kanai Y., Ochiai A., Nawata H., Hirihashi S. (1996). E-cadherin gene mutations in signet ring cell carcinoma of the stomach. Jpn J Cancer Res87:843-848.
142.
Naot D., Sionov RV, Ish-Shalom D. (1997). CD44: structure, function and association with the malignant process. Adv Cancer Res71:241-319.
143.
Newham P., Humphries MJ (1996). Integrin adhesion receptors: structure, function and implications for biomedicine. Molec Med Today2:304-313.
144.
Nicholson LJ, Watt FM ( 1991). Decreased expression of fibronectin and the α5β1 integrin during terminal differentiation of human keratinocytes. J Cell Sci98:225-232.
145.
Nickoloff BJ, Griffiths CEM, Baadsgaard O., Voorhees JJ, Hanson CA, Cooper KD (1989). Markedly diminished epidermal keratinocyte expression of intercellular adhesion molecule 1 (ICAM-1) in Sezary syndrome. J Am Med Assoc261:2217-2221.
146.
Nickoloff BJ, Griffiths CEM, Barker Jnwn (1990). The role of adhesion molecules, chemotactic factors and cytokines in inflammatory and neoplastic skin disease. J Invest Dermatol94:151-157.
147.
Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ (1999). N-cadherin promotes motility in human breast cancer cells regardless of E-cadherin expression. J Cell Biol147:631-644.
148.
Nishimura S., Chung YS, Yashiro M., Inoue T., Sowa M. ( 1996). CD44H plays an important role in peritoneal dissemination of scirrhous gastric cancer cells. Jpn J Cancer Res87:1235-1244.
149.
Niu J., Gu X., Turton J., Meldrum C., Howard EW, Agrex M. (1998). Integrin mediated signaling of gelatinase B secretion in colon carcinoma cells. Biochem Biophys Res Commun249:287-291.
150.
Okahara H., Yagita H., Miyake K., Okumura K. (1994). Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor alpha enhancement of experimental metastasis. Cancer Res54:3233-3236.
151.
Oliveira DT, Odell EW (1997). Expression of CD44 variant exons by normal oral epithelia. Oral Oncol35:260-262.
152.
Oliveira DT, Sherrif M., Odell EW (1998). Expression of CD44 variant exons by primary and metastatic oral squamous carcinomas. J Oral Pathol Med27:303-307.
153.
Osborn L., Hession C., Tizard R., Vassalo C., Luhowskyj S., Chi-Rosso G., et al. (1989). Direct expression cloning of a vascular cell adhesion molecule 1, a cytokine induced endothelial protein that binds to lymphocytes. Cell59:1203-1211.
154.
Otey CA, Pavalko FM, Burridge K. (1990). An interaction between a actinin and the β1 integrin subunit in vitro. J Cell Biol111:721-729.
155.
Pietrzak ER, Savage NW, Aldred MJ, Walsh LJ (1996). Expression of the E-selectin gene in human gingival epithelial tissue. J Oral Pathol Med25:320-324.
156.
Piffko J., Bankfalvi A., Klauke K., Dreier R., Joos U., Bocker W., et al. (1996). Unaltered strong immunohistochemical expression of CD44-v6 and -v5 isoforms during development and progression of oral squamous cell carcinomas. J Oral Pathol Med25:502-506.
157.
Pignatelli M., Smith MEF, Bodmer WF (1990). Low expression of collagen receptors in moderate and poorly differentiated colorectal adenocarcinoma. Br J Cancer61:636-638.
158.
Pignatelli M., Cardillo MR, Hanby A., Stamp GWH (1992a). Integrins and their accessory adhesion molecules in mammary carcinomas: loss of polarisation in poorly differentiated tumours. Hum Pathol23:1169-1176.
159.
Pignatelli M., Liu D., Nasim MM, Stamp GWH, Hirano S., Takeichi M. (1992b). Morphoregulatory activities of E- cadherin and beta-1 integrins in colorectal tumour cells. Br J Cancer66:629-634.
160.
Pignatelli M., Ansari TW, Gunter P., Liu D., Hirano S., Takeichi M., et al. (1994). Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade and advanced stage. J Pathol174:243-248.
Renkonen J., Makitie A., Paavonen T., Renkonen R. (1999). Sialyl-Lewis (x/a)-decorated selectin ligands in head and neck tumours. J Cancer Res Clin Oncol125:569-576.
Roye GD, Myers RB, Brown D., Poczatek R., Beenken SW, Grizzle WE (1996). CD44 expression in dysplastic epithelium and squamous cell carcinoma of the oesophagus. Int J Cancer69:254-258.
165.
Rubinfeld B., Robbins P., El-Gamil M., Albert I., Portfiri E., Polakis P. (1997). Stabilisation of (3-catenin by genetic defects in melanoma cell lines. Science275:1990-1992.
166.
Sakaki T., Wato M., Kaji R., Mushimoto K., Shirasu R., Tanaka A. (1994). Correlation of E- and P-cadherin expression with differentiation grade and mode of invasion in gingival carcinoma. Path Int44:280-286.
167.
Salmi M., Gron-Virta K., Sointu P., Grenman R., Kalimo H., Jalkanen S. (1993). Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumours of squamocellular origin. J Cell Biol122:431-442.
168.
Sass PM ( 1998). The involvement of selectins in cell adhesion, tumour progression and metastasis. Cancer Invest16:322-328.
169.
Scher RL, Koch WM, Richtsmeier WJ (1993). Induction of the intercellular adhesion molecule (ICAM-1) on squamous cell carcinoma by interferon gamma. Arch Otolaryngol Head Neck Surg119:432-438.
170.
Schipper JH, Frixen UH, Behrens J., Unger A., Jahnke K., Birchmeier W. (1991). E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res51:6328-6337.
171.
Schipper JH, Unger A., Jahnke K. (1994). E-cadherin as a functional marker of the differentiation and invasiveness of squamous cell carcinoma of the head and neck. Clin Otolaryngol19:381-384.
172.
Schoenwaelder M., Burridge K. (1999). Bidirectional signaling between the cytoskeleton and integrins. Curr Opin Cell Biol11:274-286.
173.
Schreiner C., Fisher M., Hussein S., Juliano RL (1991). Increased tumorgenicity of fibronectin receptor deficient Chinese hamster ovary cell variants. Cancer Res51:1738-1740.
174.
Schwartz MA (1994). Integrins as signal transducing receptors. In: Integrins; molecular and biological responses to the extracellular matrix. Cheresh DA, Mecham RP, editors. New York: Academic Press, pp. 33-47.
175.
Screaton GR, Bell MV, Bill JI ( 1993). The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human and rat. J Biol Chem268:12235-12238.
176.
Seftor REB, Seftor EA, Stetler-Stevenson WG, Hendrix MJC (1993). The 72kDa type IV collagenase is modulated via differential expression of alpha v beta 3 and alpha 5 beta 1 integrins during human melanoma cell invasion. Cancer Res53:3411-3415.
177.
Sheen-Chen SM, Chen WJ, Eng HL, Sheen CC, Chou FF, Cheng (1999). Evaluation of the prognostic value of serum soluble CD44 in patients with breast cancer. Cancer Invest17:581-585.
178.
Shimoyama Y., Hirohashi S. (1991a). Cadherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Lett57:131-135.
179.
Shimoyama Y., Hirohashi S. (1991b). Expression of E- and P-cadherin in gastric carcinoma. Cancer Res51:2185-2192.
180.
Shimoyama Y., Hirohashi S., Hirano S., Noguchi M., Shimosato Y., Takeichi M., et al. (1989). Cadherin cell adhesion molecules in human epithelial tissue and carcinomas. Cancer Res49:2128-2133.
181.
Shinohara M., Nakamura S., Sasaki M., Kurahara S., Ikebe T., Harada T., et al. (1999). Expression of integrins in squamous cell carcinoma of the oral cavity. Correlations with tumour invasion and metastasis. Am J Pathol111:75-88.
182.
Simmons DL (1999). The immunoglobulin superfamily. In: Advances in molecular and cell biology. Garrod D, North A, Chidgey M, editors. JAI Press Inc., pp. 113-132.
183.
Sorscher SM, Russack V., Cagle M., Feramisco JR, Green MR (1995). Immunolocalisation of E-cadherin in human head and neck cancer. Arch Path Lab Med119:82-84.
184.
Springer TA (1990). Adhesion receptors of the immune system. Nature346:425-434.
185.
Stappert J., Kemler R. (1999). The cadherin superfamily. In: Advances in molecular and cell biology. Garrod D, North A, Chidgey M, editors. JAI Press Inc., pp. 27-63.
186.
Steeber DA, Campbell MA, Basit A., Ley K., Tedder TF (1998). Optimal selectin-mediated rolling of leukocytes during inflammation in vivo requires intercellular adhesion molecule-1 expression. Proc Natl Acad Sci USA95:7562-7567.
187.
Sugiyama M., Speight PM, Prime SS, Watt FM ( 1993). Comparison of integrin expression and terminal differentiation capacity in cell lines derived from oral squamous cell carcinoma. Carcinogenesis14:2171-2176.
188.
Suzuki ST (1996). Structural and functional diversity of cadherin superfamily-are new members of cadherin superfamily involved in signal transduction pathway. J Cell Biochem61:531-542.
189.
Symington BE, Carter WG (1995). Modulation of epidermal differentiation by epiligrin and integrin α3β1. J Cell Sci108:831-838.
190.
Symington FW, Holmes EH, Symington BE (1992). Human epidermal keratinocyte expression of sialyl-Lewis X. J Invest Dermatol99:601-607.
191.
Takada A., Ohmori K., Takahashi N., Tsuyuoka K., Yago A., Zenita K., et al. (1991). Adhesion of human cancer cells to vascular endothelium mediated by carbohydrate antigen, sialyl Lewis A. Biochem Biophys Res Commun179:713-719.
192.
Takada M., Yamamoto M., Saitoh Y. (1994). The significance of CD44 in human pancreatic cancer. High expression of CD44 in human pancreatic adenocarcinoma. Pancreas9:748-752.
193.
Takahashi K., Eto H., Tanabe KK (1999). Involvement of CD44 in matrix metalloproteinase-2 regulation in human melanoma cells. Int J Cancer80:387-395.
194.
Takeichi M. (1990). Cadherins: a molecular family important in selective cell-cell adhesion. Annu Rev Biochem59:237-252.
195.
Takeichi M. (1991). Cadherin cell adhesion receptors as a morphogenic regulator. Science251:1451-1455.
196.
Takeichi M. (1993). Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol5:806-811.
197.
Tamura S., Shiozaki H., Miyata M., Kadowaki T., Inoue M., Matsui S., et al. (1996). Decreased E-cadherin expression is associated with haematogenous recurrence and poor prognosis in patients with squamous cell carcinoma of the oesophagus. Br J Surg83:1608-1614.
198.
Tanabe KK, Saya H. ( 1994). The CD44 adhesion molecule and metastasis. Crit Rev Oncogenesis5:2-3.
199.
Tanabe KK, Ellis LM, Saya H. ( 1993). Expression of CD44R1 adhesion molecule in colon carcinomas and metastasis. Lancet341:725-726.
200.
Tanaka Y., Adams DH, Shaw S. ( 1993). Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today14:111-115.
201.
Tang A., Amagai M., Granger LG, Stanley JR, Udey MC ( 1993). Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature361:82-85.
202.
Tang A., Eller MS, Hara M., Yaar M., Hirohashi S., Gilcrest BA (1994). E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J Cell Sci107:983-992.
203.
Tedder TF, Li X., Steeber DA (1999). The selectins and their ligands. In: Advances in molecular and cell biology. Garrod D, North A, Chidgey M, editors. JAI Press Inc., pp. 65-111.
204.
Tenchini ML, Adams JC, Gilberty C., Steel J., Hudson DL, Malcovati M., et al. (1993). Evidence against a major role for integrins in calcium dependent intercellular adhesion of epidermal keratinocytes. Cell Adhes Comm1:55-66.
205.
Thomas GJ, Poomsawat S., Lewis MP, Hart IR, Speight PM, Marshall JF (2001a). Alpha v beta 6 integrin upregulates matrix metalloproteinase 9 and promotes migration of normal oral keratinocytes. J Invest Dermatol116: 898-904.
206.
Thomas GJ, Lewis MP, Whawell SA, Russell A., Hart IR, Speight PM, et al. (2001b). av(36 integrin promotes invasion and migration in squamous carcinoma cells. J Invest Dermatol117: 67-73.
207.
Thomas GJ, Lewis MP, Hart IR, Marshall JF, Speight PM (2001c). Alpha V beta 6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9. Int J Cancer92: 641-650.
208.
Thomas GJ, Jones J., Speight PM (1997). Integrins in oral cancer. Oral Oncol33:381-388.
209.
Thomas GJ, Lewis MP, Whawell SA, Russell A., Sheppard D., Marshall JF, et al. (1999). Expression of the av(36 integrin in squamous carcinoma cells promotes multiple aspects of cell behaviour associated with malignancy. Cancer Res (manuscript submitted).
210.
Toma V., Hauri D., Schmid U., Ackermann D., Maurer R., Alund G., et al. (1999). Focal loss of CD44 variant protein expression is related to recurrence in superficial bladder cancer. Am J Pathol155:1427-1432.
211.
Tomson AM, Scholma J., Meijer B., Koning JG, de Jong KM, van der Werf M. (1996). Adhesion properties, intermediate filaments and malignant behaviour of head and neck squamous cell carcinoma cells in vitro. Clin Exp Metastasis14:501-511.
212.
Tsujisaki M., Imai K., Hirata H., Hanzawa Y., Matsuya J., Nakano T., et al. (1991). Detection of circulating intercellular adhesion molecule 1 antigen in malignant disease. Clin Exp Immunol85:3-8.
213.
Ue T., Yokozaki H., Kagai K., Higashikawa K., Yasui W., Sugiyama M., et al. (1998). Reduced expression of the CD44 variant exons in oral squamous cell carcinoma and its relationship to metastasis. J Oral Pathol Med27:197-201.
214.
Umbas R., Schalken JA, Aalders TW, Carter BJ, Karthaus HF, Schaafsma HE, et al. (1992). Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high grade prostatic cancer. Cancer Res52:5104-5109.
215.
Van Hal NL, Van Dongen GA, Rood Knippels EM, Van Der Valk P., Snow GB, Brakenhoff RH (1996). Monoclonal antibody U36, a suitable candidate for clinical immunotherapy of squamous cell carcinoma, recognises a CD44 isoform. Int J Cancer68:520-527.
216.
Varki A. (1994). Selectin ligands. Proc Natl Acad Sci USA91:7390-7397.
217.
Varner JA, Emerson DA, Juliano RL (1995). Mol Biol Cell6:725-740.
218.
Vleminckx K., Vakaet LJ, Mareel M., Fiers W. Van RF, (1991). Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell66:107-119.
219.
Vogetseder W., Feichtinger H., Schultz TF, Schwaeble W., Tabaczewski P., Mitterer M., et al. (1989). Expression of 7F7 antigen, a human adhesion molecule identical to intercellular adhesion molecule-1 (ICAM-1) in human carcinomas and their stromal fibroblasts. Int J Cancer43:768-773.
220.
Walsh LJ, Coyne RM, Xu LJ, Savage NW (1996). The role of cell adhesion molecules on oral cancer. Aust Dent J41:80-82.
221.
Walton LJ, Thornhill MH, Farthing PM (1994). VCAM-1 and ICAM-1 are expressed by Langerhans cells, macrophages and endothelial cells in oral lichen planus. J Oral Pathol Med23:262-268.
222.
Wawryck SO, Novotny JR, Wicks IP, Wilkinson D., Maher D., Salvaris E., et al. (1989). The role of the LFA/ICAM-1 interaction in human leukocyte homing and adhesion. Immunol Rev108:135-161.
223.
Weaver V., Peterson O, Laarabell C., Briand P., Damsky C., Bissell M. (1997). Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol137:231-245.
224.
Wenzel CT, Scher RL, Richtsmeier WJ (1995). Adhesion of head and neck squamous cell carcinoma to endothelial cells. The missing links. Arch Otolaryngol Head Neck Surg121:1279-1286.
225.
Wheelock MJ, Buck CA, Bechtol KB, Damsky CH (1987). Soluble 80 kD fragment of cell-CAM 120/80 disrupts cell-cell adhesion. J Cell Biochem 34:117, 415-425.
226.
Wilding J., Vousden KH, Soutter WP, McCrea PD, Del Bouno R., Pignatelli M. (1996). E-cadherin transfection down-regulates the epidermal growth factor receptor and reverses the invasive phenotype of human papilloma virus-transfected keratinocytes. Cancer Res56:5285-5292.
227.
Williams HK, Sanders DS, Jankowski JA, Landini G., Brown AM (1998). Expression of cadherins and catenins in oral epithelial dysplasia and squamous cell carcinoma. Oral Pathol Med27:308-317.
228.
Wolf GT, Carey TE, Schmatz SP, McClatchey KD, Poore J., Glaser L., et al. (1990). Altered antigen expression predicts outcome in squamous cell carcinoma of the head and neck. J Natl Cancer Inst82:566-572.
229.
Yamada K., Jordan RCK, Mori M., Speight PM (1997). The relationship between E-cadherin expression, clinical stage and tumour differentiation in oral squamous cell carcinoma. Oral Diseases3:82-85.
230.
Yamada KM, Kennedy DW (1984). Dualistic nature of adhesive protein function: fibronectin and its biologically active peptide fragments can autoinhibit fibronectin function. J Cell Biol99:29-36.
231.
Yamada KM, Miyamoto S. (1995). Integrin transmembrane signaling and cytoskeletal control. Curr Opin Cell Biol7:681-689.
232.
Yu Q., Stamenkovic I. (1999). Localisation of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44 mediated tumour invasion. Genes Dev13:35-48.
233.
Zhang Z., Vuori K., Reed JC, Ruoslahti E. (1995). The α5β1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2. Proc Natl Acad Sci USA92:6161-6165.
234.
Zhou J., Haggerty JG, Milstone LM (1999). Growth and differentiation regulate CD44 expression on human keratinocytes. In vitro Cell Dev Biol Animal35:228-235.
235.
Zhu A., Watt FM ( 1996). Expression of a dominant negative cadherin mutant inhibits proliferation and stimulates terminal differentiation of human epidermal keratinocytes. J Cell Sci109:3013-3023.
